Tesla's $25 billion capital expenditure plan for its Optimus humanoid robot faces skepticism as the Chinese robotics sector experiences a sharp correction. With industry bellwether Unitree down 55% from its highs, regulators are tightening IPO requirements, casting doubt on the sustainability of government-backed revenue models and the broader consumer demand for high-cost humanoid hardware.
Unitree's stock has dropped 55% from its all-time high amid Chinese regulatory scrutiny and questions about the sustainability of its revenue from government-backed projects.